Mireya Jimeno Selected Research

Formaldehyde (Formol)

1/2022

Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mireya Jimeno Research Topics

Disease

3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2011
2	Ulcerative Colitis 01/2022 - 07/2014
2	Adenoma (Adenomas) 01/2022 - 01/2014
2	Aberrant Crypt Foci 01/2019 - 01/2014
1	Neoplasms (Cancer) 01/2017
1	Carcinogenesis 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Inflammation (Inflammations) 07/2013
1	Plasma Cell Granuloma 05/2012
1	Infections 05/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2007

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	ParaffinIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2017
1	Keratin-19 (Keratin 19)IBA 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 07/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 07/2013
1	Cetuximab (Erbitux)FDA Link 01/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2011
1	Panitumumab (Vectibix)FDA Link 01/2011
1	Transcription Factors (Transcription Factor)IBA 08/2007

Therapy/Procedure

1	Laparotomy 05/2012
1	Drug Therapy (Chemotherapy) 05/2012